Table 1.
Overview of Cases in the Two Cohorts, and Distribution of NPM1 Mutations
| |
|
Training cohort |
Validation cohort |
||
|---|---|---|---|---|---|
| NPM1 status | Label | n | % | n | % |
| NPM1 WT | Neg | 350 | 69.3% | 72 | 50.3% |
| NPM1 non-ABD | Neg | 10 | 2.0% | 5 | 3.5% |
| NPM1 A (TCTG) | Pos | 123 | 24.4% | 56 | 39.2% |
| NPM1 B (CATG) | Pos | 15 | 3.0% | 8 | 5.6% |
| NPM1 D (CCTG) | Pos | 7 | 1.4% | 2 | 1.4% |
| Total | 505 | 100.0% | 143 | 100.0% | |